Recent Headlines
Within Pharmaceuticals
Mirror Biologics Announces Issuance of US Patent Covering Next Generation Therapeutic Vaccine Technology for Treatment of Cancer and Infectious Disease
Mirror Biologics, Inc., a private clinical stage biopharmaceutical company, today announces the issuance of US Patent No. 11,160,852, “Method of Vaccinating Using Allogeneic Cells,” covering methods for creating a next generation of therapeutic vaccines against cancers and infectious... - November 17, 2021 - Mirror Biologics, Inc.
Innovation Saves Lives Amid Darkest Moments of COVID-19 Pandemic
"Effective communication is paramount and it works best when combined with trust. When there is a pandemic or another crisis that affects the human race, we should use our capabilities to the best of our ability and find solutions - together." - Dr. Ankit Bharat, Chief of Thoracic... - November 16, 2021 - Seraph Books
South-Tek Systems Appoints Jens Bolleyer as CEO
South-Tek Systems announces Jens Bolleyer was appointed as the company’s CEO effective August 30, 2021. An experienced business leader, Mr. Bolleyer steps into the CEO role at South-Tek with significant experience in manufacturing businesses serving commercial & industrial plumbing and... - November 16, 2021 - South Tek Systems
AKARA by AAYNA: the New Weight Loss Specialist in Town
AKARA, an extension of the AAYNA clinics, is the newest luxury weight loss specialist now open in Ludhiana and Delhi(Mehrauli & Khan Market). Built to bridge the gap between the consumer’s growing need to constantly look attractive and healthy not just in front of the society but for themselves as well and the lack of a physical space that can provide world-class facilities, programs, and technologies all under the same roof. - November 15, 2021 - AKARA
Careington® Works with Great Speech to Add Virtual Speech Therapy Services to Its Telehealth Offerings Nationwide
Careington International Corporation, a leader in the non-insured health care benefits space, is pleased to begin working with Great Speech Inc., a pioneer in the virtual speech therapy space, adding virtual speech therapy to Careington’s ever-expanding telehealth offerings. This relationship... - November 11, 2021 - Careington
Saeidan Inc. Joins Techstars' Future of Longevity Accelerator
Saeidan Inc., a company transforming the experience for those navigating Medicare, has joined the 2021 Techstars Future of Longevity Accelerator program, run in partnership with Pivotal Ventures. Working with Techstars will significantly boost the company’s efforts to scale Ask Claire®... - November 10, 2021 - Saeidan
Michael J. Drabkin, MD Joins New York Imaging Specialists
NY Imaging Specialists is proud to announce the addition of Chief of Interventional Radiology (IR), Interventional Oncology for New York Cancer & Blood Specialists (NYCBS), and Executive Director of New York Interventional Radiology Specialists Michael J. Drabkin, MD. He is board-certified in... - November 09, 2021 - New York Imaging Specialists
Genetically Steady and Cost-Effective Gene Knockout Stable Cell Lines Products at Creative Biogene
Creative Biogene creatively develops a series of genetically steady and cost-effective gene knockout stable cell lines products for domestic and overseas clients. - November 06, 2021 - Creative Biogene
Eyecheck Announces FDA IND Clearance of STRI Formula, the First-Ever Food-Based, Combination Product in the STRI Phase 2 Clinical Trial for COVID-19 Symptoms
Eyecheck intends to initiate the Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial to evaluate STRI Formula in non-hospitalized adults with COVID-19. This trial is expected to begin in November 2021. - November 04, 2021 - Eyecheck, Inc.
Noble Paws CBD Joins Forces with Leading Pet Diabetes Brand
The pet CBD brand with an ethos, Noble Paws, donates a bottle of their healing CBD to a shelter every time one is purchased. Noble Paws has joined forces with rising star pet diabetes brand, PetTest, to reach as many pets as possible and “hemp” spread the word. - November 04, 2021 - Noble Paws
PharmStars Welcomes Sumitovant Biopharma as Its Newest Member
PharmStars, the only pharma-focused, member-based accelerator for digital health startups, is pleased to announce that Sumitovant Biopharma has become its newest pharma member, joining existing members including Boehringer Ingelheim, Eli Lilly and Company, and Novo Nordisk. PharmStars focuses on bridging the "pharma-startup gap." PharmStars provides startups with education and mentoring to help them engage with pharma as clients and partners. - November 03, 2021 - PharmStars
Creative Biogene Offers One-Stop Customized CRISPR-Based Microbe Genome Editing Service
CRISPR Platform is a mature system developed by Creative Biogene. Services like microbe’s gene knockout and gene knock-in central to the gene-editing area can be precisely performed based on the CRISPR platform. As a popular and useful tool in microbe genome editing, the CRISPR platform always presents excellent performance and serves quality-guaranteed results in a wide range of projects. - November 03, 2021 - Creative Biogene
Cord for Life®, Inc. Announces Cord Blood Clinical Trial Phase I Trial for the Treatment of Lower Back Pain of the Sacroiliac Joint
Cord for Life®, a full-service cord blood bank with over 25 years of experience, today announced plans to conduct a clinical trial to treat lower back pain arising from the Sacroiliac Joint (SIJ) using a biological therapeutic derived from umbilical cord blood. The company has received FDA... - October 29, 2021 - Cord For Life
Pascal Biosciences Announces Financing
Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV: PAS) (OTC: PSCBF) (FSE: 6PB-FF) is pleased to announce a non-brokered private placement financing of up to 9,000,000 units (each a “Unit”) of securities at a price of $0.10 per Unit for aggregate gross proceeds of up to $900,000.00 (the “Offering”). - October 29, 2021 - Pascal Biosciences
uMore Reveals Its Inaugural Impact Report, with a Resounding 84% Positive Feedback Response
uMore, the Miami-based mental health start-up dedicated to enabling individuals to self-manage their mental health released its inaugural Impact Report, highlighting the mobile app's self-care activities released with the new application. - October 23, 2021 - uMore
Families of World War II Veterans Holds 2021 Fundraising Golf Tournament
Families of World War II Veterans will hold its annual golf tournament and fundraising event on Monday, October 25, 2021 at the award-winning Trinity Forest Golf Club in Dallas, Texas, the former home of the renowned AT&T Byron Nelson tournament. This year's tournament is presented by MetLife... - October 23, 2021 - Careington
New Standard on Management System Specifications Published by UK Authorised Representative Association UKARA
The new standard UKARAS 001:2021 – UK/GB Responsible Person/Authorised Representative – Management System Specification published by the UK Authorised Representative Association (UKARA). - October 23, 2021 - UKARA
ASHP Case Study on Drugs in Short Supply Highlights MedShorts Online Marketplace
The American Society of Health-System Pharmacists (ASHP) published a case study citing financial and sourcing successes for health system pharmacies utilizing the MedShorts marketplace for direct access to drugs. The data-driven marketplace consumes and analyzes data from ASHP Drug Shortages to match pharmacy needs and alleviate shortage occurrences. Read the case study: https://www.ashp.org/products-and-services/database-licensing-and-integration/ashp-drug-shortages/medshorts-case-study - October 21, 2021 - MedShorts LLC
New Ground-Breaking Treatment for Fibromyalgia Now Available at Harley Street London
TMS has been used for over 20 years to treat a variety of mental health issues. It works by either stimulating or inhibiting specific regions of the brain, helping to return the activity levels of these areas back to normal. At TMS London, they use this technology to target the overactive pain-processing region of people with fibromyalgia, and reduce this activity back to healthy levels, enabling them to help their patients to feel less pain and have an improved quality of life. - October 21, 2021 - Dr. Stephanie Barrett, Consultant Physician and Rheumatologist
Radformation and Aplicaciones Tecnológicas de la Física Launch Automation Partnership at Institut Català d'Oncologia
Radformation, together with their distributor in Spain, Aplicaciones Tecnológicas de la Física, is pleased to announce a partnership with Institut Català d'Oncologia. Institut Català d'Oncologia (ICO) will utilize Radformation’s suite of automation software to... - October 21, 2021 - Radformation
Swiss Start-Up HealthyCheck Transforms the Way People Monitor Their Health Directly from Home
HealthyCheck today announces the launch of its new platform to transform the way people monitor their health. HealthyCheck is a start-up that focuses on providing many laboratory tests to the user directly from home. Users enjoy an easy and convenient way to test their health and monitor long term... - October 20, 2021 - HealthyCheck
Burn Boot Camp Robinson, PA Participates in Third Annual National "Be Their Muscle" Event
National Fitness Franchise, Burn Boot Camp, Holds Nationwide Camps on October 30 Benefitting Muscular Dystrophy Association (mda.org) as Company Closes in on $1 Million Fundraising Goal. - October 18, 2021 - Burn Boot Camp Robinson, PA
OmeCare and Hillsborough City School District Renew Partnership for Student and Faculty COVID-19 PCR Testing
Partnership helps district ensure safety standards and meet COVID-19 testing protocols for the 2021-2022 school year. - October 16, 2021 - OmeCare
Impact Landscape Survey 2021 Illuminates Global Research Impact Trends
International impact experts, Vertigo Ventures (VV), today announced the release of the Impact Landscape Survey 2021. The report delves into global perspectives on impact, primarily drawn from academics in Australia and the UK, covering areas such as prioritisation of research impact, progress... - October 15, 2021 - Vertigo Ventures
NuvOx Pharma Receives Phase I STTR Grant from NINDS for Preclinical Studies in Stroke
NuvOx Pharma, a Tucson based biotechnology company, has received a $478,000 NIH Phase I Small Business Technology Transfer (STTR) grant from the National Institute of Neurological Disorders and Stroke (NINDS) under award number R41NS124450. STTR programs are highly competitive programs that... - October 12, 2021 - NuvOx Therapeutics
Pipelinepharma Closes €1.3M Seed Round to Shift Pharmaceutical Dealmaking Online
The European B2B pharmaceutical marketplace closed a venture seed round led by Practica Capital. Iron Wolf Capital, Pandos and a group of angel investors also participated in the funding round. - October 09, 2021 - Pipelinepharma
Mary Crowley Cancer Research Welcomes New Chief Executive Officer, Jon Friedenberg
Jon Friedenberg brings a wealth of experience in healthcare leadership to his new appointment as Chief Executive Officer at Mary Crowley Cancer Research. - October 07, 2021 - Mary Crowley Cancer Research
NY Imaging Specialists Brings the Future of Medical Imaging to Nassau County
NY Imaging Specialists today announced the opening of a brand-new comprehensive imaging center in Nassau County. The center includes advanced imaging technology, a women’s health center, an interventional radiology suite, and an adjoining New York Cancer & Blood Specialists medical... - October 04, 2021 - New York Imaging Specialists
Omni-HC Selected to Participate in “Audience Amplification” Workshop at Prestigious Global Medical Affairs Meeting
Omni Healthcare Communications has been selected by the Medical Affairs Professional Society to convene a workshop on scientific communication amplification at the MAPS 2022 Global Annual Meeting. - October 02, 2021 - Sunny Ayr Holdings
OmeCare and LifeSite Announce COVID-19 Testing Solution Partnership
The partnership provides a turnkey approach for workplaces, schools, major conventions and other group events looking to ensure safety and meet governmental mandates for students, staff, employees and event participants. - October 01, 2021 - OmeCare
“Essentials of Diagnosis, Treatment and Application of Cardiac and Peripheral Vascular Diseases” is About to be Released on Amazon, Barnes & Noble Nook and Apple Books
The physical version of the medical research book, “Essentials of Diagnosis, Treatment, and Application of Cardiac and Peripheral Vascular Diseases (Theories, Cases and Analysis)” was published by American Harmony Medical Academic Publisher (AHMAP) on July 26, 2021. - October 01, 2021 - American Harmony Medical Academic Publisher
Launch of TrackImpact.org to Accelerate Global Collaboration Towards a Sustainable Future
International impact experts, Vertigo Ventures (VV), yesterday announced the release of TrackImpact.org, the global research collaboration platform, at the 2021 Impact Symposium. TrackImpact™ is a free-to-access solution that accelerates positive social, economic and environmental impact by... - September 30, 2021 - Vertigo Ventures
Careington CIO, Rashmi Jain, to be a Panelist at the Women in Tech Summit
Careington International Corporation proudly announces Chief Information Officer Rashmi Jain will speak at the Women in Tech Summit. This event will take place during InnoTech Dallas on Tuesday, September 28 at the Irving Convention Center. The “Lessons from the Leaders” panel... - September 30, 2021 - Careington
Pathologist Creates First Open Source Direct Vision Microscope with an AR Interface - Which You Can Build with a 3D Printer
A UK Pathologist has combined his knowledge of microscopy and 3D printing to develop the world's first direct vision DIY printable advanced microscopy system with features not even seen on the most expensive commercial research microscopes - and has made it all Open Source. The PUMA microscope system is poised to be a game changer in the democratization of microscopy and is totally portable for use in remote field work. See the "PUMA Microscope" YouTube channel for more. - September 27, 2021 - PUMA
Careington Announces Launch of QuoteSavant, a New Insurance Comparison Service
Careington International Corporation is excited to announce the launch of QuoteSavant, a customer-first insurance comparison service, and the newest addition to its affiliate company Careington Benefit Solutions, a nationally licensed Third Party Administrator and agency. - September 22, 2021 - Careington
Cayman Chemical Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage... - September 19, 2021 - Cayman Chemical Company
AdvantaPure(R) Announces Fall Trade Show Appearances - Includes Events in the Northeast U.S.
AdvantaPure, the high purity division of NewAge Industries, will exhibit its silicone and TPE tubing and molded assemblies at the ISPE Boston Show, BioProcess International 2021, and Interphex, all taking place in September and October. AdvantaPure will also highlight its recent clean room expansion and its in-process building renovation at the events. The company is increasing its tubing manufacturing capacity to help meet demand for its Single-Use products. - September 16, 2021 - AdvantaPure
MEDraysintell Publishes the 8th Edition of Its Nuclear Medicine Report & Directory
A set of three volumes (3,100 pages) with a description of 870 products, together with a comprehensive profile of 340 companies active around the world in the radiopharmaceutical industry. - September 16, 2021 - MEDraysintell
Synformulas Presents the Scientifically Researched Potential of Its Products for the First Time at Vitafoods Europe
Common diseases such as gastrointestinal conditions and allergies are the focus of the company’s research and product development; More value is being added for further licensing and distribution partners through strong scientific research results; SYNformulas is seeking for additional distribution partners to expand its internationalization activities with its patented active complexes. - September 13, 2021 - SYNformulas
Clean-Label Micellar Water Formulation Banishes Trace Chemicals and Outperforms Leading Brand
Locus Performance Ingredients and Genomatica introduce sustainable, natural cleanser featuring Ferma® S sophorolipids and Brontide® natural butylene glycol that eliminates chemical additives and outperforms the current leading brand. The next-generation micellar water replaces controversial legacy ingredients with plant-derived ingredients that provide all the traditional micellar water benefits, but with superior functionality and sustainability. - September 11, 2021 - Locus Performance Ingredients
Mirror Biologics, Inc. Announces Initial Clearance for Phase II/III Clinical Trial (ALIVE) in Advanced Liver Cancer
Mirror Biologics, Inc, (“Mirror Biologics” or the “Company”), a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ vaccine immunotherapy for cancer and infectious diseases where... - September 10, 2021 - Mirror Biologics, Inc.
Globally Recognized Agricultural Leader to Become First N.C. PSI Director
Adrian Percy, one of the world’s top leaders in the agriculture field, is set to become the first executive director of the North Carolina Plant Sciences Initiative (N.C. PSI): a world-class research and innovation effort that is poised to solve some of the world’s grandest agricultural... - September 09, 2021 - North Carolina Plant Sciences Initiative
Locus Performance Ingredients Launches New Biosurfactant-Based Personal Care Formulations to Ease Adoption of Clean Label Trend
Ready-to-use formulations utilizing novel Ferma® S sophorolipids help CPG companies replace commonly used surfactants, boost product performance and maximize sustainability. - September 09, 2021 - Locus Performance Ingredients
NuvOx Pharma Generates Positive Preclinical Data Showing NanO2TM Boosts the Efficacy of Immunotherapy in a Mouse Model of Triple Negative Breast Cancer
NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has generated positive preclinical data showing that its lead drug, NanO2TM, boosts the efficacy of immunotherapy in a mouse model of triple negative breast cancer. Triple negative breast cancer (TNBC) is a particularly deadly form of... - September 09, 2021 - NuvOx Therapeutics
Aelius LED Office Expansion Improves Efficiency for Cultivators Worldwide
Canadian LED Grow Light Experts Move Into New Facility - September 07, 2021 - AeliusLED
Scientists at AbboMax, Inc. Developed the New Panels of Monoclonal Antibodies to Study B- and T-Cell Lymphomas
Lymphoma is a malignant transformation of either B or T cells or their subtypes. All lymphoma subtypes combined are the seventh most common cancer in the United States. The B-cell lymphomas are types of lymphoma affecting B cells. About 85% of lymphomas are of B-cell origin. T-cell lymphomas are lymphomas that affect T cells. AbboMax has developed the new panels of monoclonal antibodies to study B- and T-cell lymphomas. - September 03, 2021 - AbboMax, Inc.
NANETS Announces 2021 Basic/Translational Science Investigator Award (BTSI) Recipient
The North American Neuroendocrine Tumor Society (NANETS) congratulates J. Barton Rose, III, MD, MAS, FACS of the University of Alabama, as the 2021 recipient of NANETS’ Basic/Translational Science Investigator Award (BTSI). Dr. Rose was awarded this scholarship for his proposal: Molecular influences of racial disparities in pancreatic neuroendocrine tumors. - August 31, 2021 - NANETS
North American Neuroendocrine Tumor Society Announces 2021 NANETS Clinical Investigator Scholarship Award Recipient
The North American Neuroendocrine Tumor Society (NANETS) congratulates Jessica E. Maxwell, MD, as the 2021 recipient of the NANETS Clinical Science Investigator Award (NCIS). She was awarded this scholarship for her proposal: Characterization of the small bowel neuroendocrine tumor immune environment. - August 31, 2021 - NANETS
Defined Bioscience Licenses FGF2-STAB (G3) for Use in Stem Cell Media
Defined recently concluded a licensing agreement with Czech Republic-based Enantis for global use of Enantis’ patented FGF2-STAB® technology both alone and in stem cell media formulations. FGF2-STAB®, originally coined FGF2-G3, was developed by Enantis and Masaryk University, using... - August 30, 2021 - Defined Bioscience Inc.
Locus Performance Ingredients Forms Industry-Leading Advisory Board to Accelerate Global Use of Biosurfactant Innovations
The panel of top CPG and entrepreneurial executives will drive adoption of sustainable biosurfactant ingredients in product formulations. - August 26, 2021 - Locus Performance Ingredients